List of works - Erik Stoops

A Novel Tau Antibody Detecting the First Amino-Terminal Insert Reveals Conformational Differences Among Tau Isoforms

scientific article published on 31 March 2020

A new era of CSF biomarker testing in the field of Alzheimer's disease

scholarly article by Sebastiaan Engelborghs et al published July 2013 in Alzheimer's and Dementia

Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid - method comparison and round robin study

scientific article published on 13 November 2018

Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements

article

Automation on an Open-Access Platform of Alzheimer's Disease Biomarker Immunoassays

scientific article published on 18 January 2018

C-Reactive Protein, Plasma Amyloid-β Levels, and Their Interaction With Magnetic Resonance Imaging Markers

scientific article published on 01 November 2018

CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation

scientific article

Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt-Jakob Disease and Synucleinopathy

scientific article published on 22 August 2018

Cerebrospinal fluid levels of synaptic and neuronal integrity correlate with gray matter volume and amyloid load in the precuneus of cognitively intact older adults

scientific article published on 20 March 2019

Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology: How specific are the conformation-specif

scientific article published on 21 September 2020

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology

scientific article published on 28 September 2020

Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements

scientific article published on 01 November 2018

Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis

scientific article published on 05 December 2020

Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia

scientific article published on 28 July 2017

Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays

scientific article published on 17 January 2020

First amyloid β1-42 certified reference material for re-calibrating commercial immunoassays

scientific article published on 04 August 2020

Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected

scientific article published on 10 November 2020

Optimized Standard Operating Procedures for the Analysis of Cerebrospinal Fluid Aβ42 and the Ratios of Aβ Isoforms Using Low Protein Binding Tubes

scientific article published on 31 May 2016

Parkinson's disease biomarkers based on α-synuclein

scientific article published on 28 July 2019

Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine

scientific article published on 22 July 2016

Plasma Amyloid-β Levels, Cerebral Small Vessel Disease, and Cognition: The Rotterdam Study

scientific article published in January 2017

Plasma Aβ (Amyloid-β) Levels and Severity and Progression of Small Vessel Disease.

scientific article published on 14 March 2018

Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study.

scientific article published on 30 June 2018

Potential sources of interference on Abeta immunoassays in biological samples

scientific article published on 17 October 2012

Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition

scientific article published on 14 October 2016

Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs

scientific article

Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40)

scientific article

List of works by Erik Stoops

A Novel Tau Antibody Detecting the First Amino-Terminal Insert Reveals Conformational Differences Among Tau Isoforms

A new era of CSF biomarker testing in the field of Alzheimer's disease

Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid - method comparison and round robin study

Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements

Automation on an Open-Access Platform of Alzheimer's Disease Biomarker Immunoassays

C-Reactive Protein, Plasma Amyloid-β Levels, and Their Interaction With Magnetic Resonance Imaging Markers

CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation

Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt-Jakob Disease and Synucleinopathy

Cerebrospinal fluid levels of synaptic and neuronal integrity correlate with gray matter volume and amyloid load in the precuneus of cognitively intact older adults

Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology: How specific are the conformation-specif

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology

Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements

Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis

Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia

Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays

First amyloid β1-42 certified reference material for re-calibrating commercial immunoassays

Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected

Optimized Standard Operating Procedures for the Analysis of Cerebrospinal Fluid Aβ42 and the Ratios of Aβ Isoforms Using Low Protein Binding Tubes

Parkinson's disease biomarkers based on α-synuclein

Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine

Plasma Amyloid-β Levels, Cerebral Small Vessel Disease, and Cognition: The Rotterdam Study

Plasma Aβ (Amyloid-β) Levels and Severity and Progression of Small Vessel Disease.

Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study.

Potential sources of interference on Abeta immunoassays in biological samples

Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition

Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs

Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40)